Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Oct 2;15(10):e0240178. doi: 10.1371/journal.pone.0240178

Occurrence of Brucella ceti in striped dolphins from Italian Seas

Giuliano Garofolo 1, Antonio Petrella 2, Giuseppe Lucifora 3, Gabriella Di Francesco 1, Giovanni Di Guardo 4, Alessandra Pautasso 5, Barbara Iulini 6, Katia Varello 6, Federica Giorda 6,7, Maria Goria 6, Alessandro Dondo 6, Simona Zoppi 6, Cristina Esmeralda Di Francesco 4, Stefania Giglio 8, Furio Ferringo 2, Luigina Serrecchia 2, Mattia Anna Rita Ferrantino 2, Katiuscia Zilli 1, Anna Janowicz 1, Manuela Tittarelli 1, Walter Mignone 6, Cristina Casalone 6, Carla Grattarola 6,*
Editor: Roy Martin Roop II9
PMCID: PMC7531818  PMID: 33007030

Abstract

Brucella ceti infections have been increasingly reported in cetaceans, although a very limited characterization of Mediterranean Brucella spp. isolates has been previously reported and relatively few data exist about brucellosis among cetaceans in Italy. To address this gap, we studied 8 cases of B. ceti infection in striped dolphins (Stenella coeruleoalba) stranded along the Italian coastline from 2012 to 2018, investigated thanks to the Italian surveillance activity on stranded cetaceans. We focused on cases of stranding in eastern and western Italian seas, occurred along the Apulia (N = 6), Liguria (N = 1) and Calabria (N = 1) coastlines, through the analysis of gross and microscopic findings, the results of microbiological, biomolecular and serological investigations, as well as the detection of other relevant pathogens. The comparative genomic analysis used whole genome sequences of B. ceti from Italy paired with the publicly available complete genomes. Pathological changes consistent with B. ceti infection were detected in the central nervous system of 7 animals, showing non-suppurative meningoencephalitis. In 4 cases severe coinfections were detected, mostly involving Dolphin Morbillivirus (DMV). The severity of B. ceti-associated lesions supports the role of this microbial agent as a primary neurotropic pathogen for striped dolphins. We classified the 8 isolates into the common sequence type 26 (ST-26). Whole genome SNP analysis showed that the strains from Italy clustered into two genetically distinct clades. The first clade comprised exclusively the isolates from Ionian and Adriatic Seas, while the second one included the strain from the Ligurian Sea and those from the Catalonian coast. Plotting these clades onto the geographic map suggests a link between their phylogeny and topographical distribution. These results represent the first extensive characterization of B. ceti isolated from Italian waters reported to date and show the usefulness of WGS for understanding of the evolution of this emerging pathogen.

Introduction

Brucella is a genus of bacteria that infects many terrestrial and aquatic vertebrates [1] and brucellosis represents a widespread zoonosis and an important economic and public health problem in many areas of the world [2].

Brucella spp. infections were first described in pinnipeds and cetaceans in the early 1990’s [3, 4], in California and Scotland, and have been reported since then in several wild marine mammal species all over the world. Since 2007, isolates of Brucella spp. from marine mammals have been classified further based on molecular investigations, differences in metabolism and host-bacteria interactions, into two species, B. ceti and B. pinnipedialis that infect cetaceans and pinnipeds, respectively [5].

The occurrence of a variety of lesions caused by brucellosis in cetaceans, such as endometritis, placentitis, abortion, orchitis, mastitis, pneumonia, myocarditis, pericarditis, osteoarthritis, spinal discospondylitis, subcutaneous abscesses, hepatic, splenic or lymph node necrosis, macrophage infiltration in liver and spleen, and meningoencephalomyelitis has been demonstrated [618]. However, compared with the reported high global seroprevalence of marine mammal Brucella spp. infection, clinical disease does not appear to be common [7, 11, 19, 20], suggesting that most of the infected animals overcome clinical disease, eventually remaining Brucella carriers and shedders [14].

Based on the common infection patterns of meningitis and/or meningoencephalitis, resembling “human neurobrucellosis” [21, 22], a specific susceptibility has been suggested for the striped dolphin (Stenella coeruleoalba) [9, 11, 19, 2326]. Central nervous system (CNS) involvement in Brucella infection in man occurs in about 5–7% of the cases [1], and includes findings of meningitis, encephalitis, meningovascular disease, brain abscesses and demyelinating syndrome [21].

The dynamics of B. ceti infection in cetaceans are largely unknown, and the cell receptor(s) allowing the entry of this pathogen and the subsequent dissemination throughout cetacean host’s tissues have not yet been identified [27]. Although the role of metazoan parasites in the eco-epidemiology and pathogenesis of brucellosis in cetaceans is unclear, the localization of B. ceti in lungworms and cestoda raise the possibility that they may serve as carriers for the transmission of the infection [11, 13].

According to Multi Locus VNTR (Variable copy of Tandem Repeats) Analysis (MLVA), the marine Brucella strains can be divided into three major groups containing eight clusters [28, 29], and the Multi Locus Sequence Typing (MLST) identified 15 sequence types (STs) so far as reported at the public PubMLST repository (https://pubmlst.org/brucella/). Marine mammal Brucella strains have potential to infect and cause disease in domestic animals [30] and humans. However, only few human clinical cases have been observed to date and linked mainly to raw fish and seafood ingestion [31, 32] or to laboratory operations without proper biosafety containment [3335].

B. ceti infections have been frequently described in dolphins from both, the Atlantic and Pacific Oceans, but to date the information about isolates from marine mammals of Mediterranean Sea is limited and relatively little data exist about brucellosis in cetaceans in Italy. The detection of anti-Brucella spp. antibodies was first demonstrated in cetaceans stranded along the Spanish coast of the Mediterranean from 1997 to 1999 [36], while no evidence of seropositivity was detected in cetaceans of Italian Seas until the beginning of 2015 [16, 37].

The isolation of B. ceti in the Mediterranean Sea was first achieved in 2009, in a striped dolphin stranded along the Spanish Catalonian coast [14]. Later, in 2012, the presence was documented in four other cetaceans, two of them, one striped dolphin and one bottlenose dolphin, stranded in Spain along the same Catalonian coastline [14], and the other two, both striped dolphins, stranded in Italy, in the Tyrrhenian and the Adriatic Sea [26, 38]. Based on MLST investigations all B. ceti strains isolated in these cases belonged to ST-26 [38].

Recently, a coinfection by Brucella spp., Listeria monocytogenes and Toxoplasma gondii was confirmed using molecular methods in a striped dolphin stranded in Italy along the Ligurian coastline, and was associated with related pathological changes in brain, blubber, liver and spleen [16]. Moreover, a B. ceti ST-27 strain, previously found only in Pacific Ocean species [11, 39], was isolated from multiple lymph nodes of one bottlenose dolphin in the Croatian part of the northern Adriatic Sea, representing the evidence of this zoonotic strain in Mediterranean waters [40, 41] and in European waters in general.

In order to gain a deeper understanding about brucellosis in cetaceans in Italy, we studied eight cases of B. ceti infection detected in striped dolphins (S. coeruleoalba) stranded along the Italian shoreline from 2012 to 2018. We focused on the pathogenic role shown by the pathogen and on the genetic constitution of the strains involved, subjected to a comparative genomic analysis in order to determine the relationship of Italian isolates to those previously described in European/Mediterranean waters [42].

Materials and methods

Ethics statement

The National Reference Centre for Diagnostic Investigations on Stranded Marine Mammals (C.Re.Di.Ma.–Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Torino, Italy) and the Istituti Zooprofilattici Sperimentali (IIZZSS) are public laboratories authorized by the Italian Ministry of Health to perform systematic surveys on infectious diseases of aquatic mammals stranded on the cost of Italy. This study was done through passive surveillance sampling animals found dead, therefore the procedures applied did not harm live animals.

Dolphins

We investigated 8 cases of stranding, associated with striped dolphins found stranded dead along the Apulian (Adriatic and Ionian Seas), Ligurian (Ligurian Sea) and Calabrian (Ionian Sea) coastlines, from 2012 to 2018 that resulted positive to the isolation of B. ceti from one or more tissues.

These positive cetaceans were distributed along the Apulian (N = 6), Calabrian (N = 1) and Ligurian (N = 1) coastlines (Fig 1).

Fig 1. Stranding sites of striped dolphins infected by B. ceti under study, Italy, 2012–2018.

Fig 1

Geographical mapping was obtained by ArcGIS® software using the geographical coordinates found from the strandings. Location data (dots): Case 1 dark green: Gallipoli Lido Pizzo, Apulian coastline, Ionian Sea (39.58 N, 18.00 E) March 11th 2012. Case 2 purple: Porto Cesareo Bacino Grande, Apulian coastline, Ionian Sea (coordinates not available) October 2nd 2012. Case 3 yellow: Alimini, Otranto, Apulian coastline, Adriatic Sea (coordinates not available) November 13th 2013. Case 4 light blue: Porto Cesareo Bacino Grande, Apulian coastline, Ionian Sea (coordinates not available) December 9th 2014. Case 5 green: Savona, on the Ligurian coastline, Ligurian sea (44.94 N, 8.18 E) February 15th 2017. Case 6 red: Ardore, on the Calabrian coastline, Ionian Sea (38.11 N, 16.12 E) May 12th 2017. Case 7 pink: Maruggio, on the Apulian coastline, Ionian Sea (40.17 N, 17.35 E) December 6th 2017. Case 8 blu: Manduria, on the Apulian coastline, Ionian Sea (40.18 N, 17.40 E) November 5th 2018. The Italy map was used under a CC BY-SA copyright from OpenStreetMap contributors (https://www.openstreetmap.org/copyright/en) (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).

Necropsy and diagnostic investigations

At the time of stranding, the carcasses were submitted to the diagnostic laboratories, belonging to the network of Istituti Zooprofilattici Sperimentali laboratories, coordinated by the C.Re.Di.Ma, where a detailed post-mortem examination was performed according to standard protocols [43], depending on the carcasses’ preservation status.

Individual data, including date and location, sex, age class categories (based on total body length-TBL), decomposition code [43] and body condition [44] were recorded. The presence of helminths was estimated by macroscopic and microscopic examination of tissues. Endoparasites were preserved in 70% alcohol for microscopic identification, according to established morphological characteristics [45, 46]. Coronal sections from different brain regions (telencephalon, diencephalon, mesencephalon, pons, cerebellum, medulla) [47], as well as from all major organs, were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned at 4 μm, stained with hematoxylin and eosin, and finally examined under a light microscope.

The presence of relevant pathogens like DMV and T. gondii was investigated by PCR methods as previously reported [48, 49]. Frozen CNS tissue samples of all animals and additional organs for cases 5, 6 and 7 were tested for both pathogens.

In one case (case 5), the presence of DMV and T. gondii was also explored through immunohistochemical investigation (IHC) [50], on CNS and bladder sections, for DMV, and CNS sections, for T. gondii, respectively.

Serological investigations to estimate the presence of specific antibodies against DMV and T. gondii were also performed in two cases (5, 6) [50], specifically on serum, cerebrospinal fluid (CSF) and aqueous humor of case 5, and on serum of case 6.

Macroscopical and microscopical findings of all cases, except case 3, were recorded.

Selected tissues and/or fluids were collected for microbiological, biomolecular and serological investigations focused on Brucella infection diagnosis.

Brucella isolation and identification

The primary isolation of Brucella spp. was performed from CNS samples of all animals, and from other tissues available for cases 1, 5, 6, 7 and 8.

Specifically, the isolation of Brucella spp. was also attempted from spleen of Case 1, spleen, lung, prescapular lymph node and cerebrospinal fluid (CSF) of case 5, spleen, lung, lymph nodes and liver of case 6, spleen, lung, liver, kidney and testes of Case 7, and spleen, lung, mesenteric lymph nodes, liver and kidney of case 8.

The CNS of case 6 was submitted for bacterial isolation subsequently to the observation of microscopic lesions suggestive of neurobrucellosis, thanks to the histopathological analysis performed retrospectively on CNS tissue of the animal under study.

Cultures were performed according to the technique described in the OIE Manual of Diagnostic Tests and Vaccines [51], using both selective and non-selective solid media and enrichment broths to enhance the chance of isolating, except for tissues other than CNS of case 6.

For cases 1, 2, 3, 4, we used Farrell’s and Columbia blood Agar media, for cases 7 and 8 we added modified Thayer Martin and CITA media, while for cases 5 and 6 we used a combination of Farrell’s and CITA media. The solid media were incubated at 37°C, aerobically and in a microaerophilic atmosphere containing 5% CO2, for at least 10 days. Enrichment cultures were carried out in Brucella enrichment broth, supplemented with fetal horse serum and modified Brucella selective supplement, and incubated at 37°C in a microaerophilic atmosphere containing 5% CO2, while for cases 7 and 8 we added Thayer Martin broth. Weekly for six times or up until isolation, a loopful of the enrichment broth was streaked to Farrell’s Agar medium. Suspect colonies (circular, convex, shiny, 1–2 mm in diameter after 48–72 h) were seeded onto blood agar medium and incubated for a further 2 days before re-examination. When Brucella spp. was suspected based on the Gram’s staining [52], the colonies were tested for catalase, oxidase and urease activities [52]. Motility and slide agglutination tests with Brucella anti-A and anti-M antisera were also performed for cases 1, 2, 3, 4, 7, 8, together with nitrate reduction, H2S production and growth in the presence of CO2 for cases 5 and 6 [52].

For DNA extraction, all B. ceti isolates were subcultured in Brucella medium base (BAB; Oxoid, Hampshire, UK) and incubated in a 5–10% CO2 atmosphere at 37°C for 48 h to assess the purity of cultures and the absence of dissociation. Bacterial DNA was extracted from single colonies using Maxwell® 16 Tissue DNA Purification Kit using Maxwell® 16 Instrument (Promega, Madison, WI, USA) or High Pure DNA Template Preparation kit (Roche Diagnostics, France) according to the manufactures’ instructions.

All strains isolated from the striped dolphins under study were identified as B. ceti using the PCR-RFLP method [53] and then subjected to genomic analysis at the National and OIE Reference Laboratory for Brucellosis, Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, Teramo, Italy.

Molecular detection of Brucella spp. from tissues

Frozen tissue samples of cases 5, 6 and 7 were submitted to PCR for the detection of Brucella spp. by hemi-nested PCR targeting an outer membrane protein gene of B. abortus [54].

The reactions were loaded as previously reported using B. suis bv 2 strain Thomsen as positive control and no template control as negative control.

Specifically, molecular detection was attempted on CNS, spleen, lung, liver, pre-scapular, tracheobronchial, pulmonary lymph nodes, tongue and skin ulcers, laryngeal tonsil and CSF of case 5; on CNS of case 6; on CNS, spleen, liver, lung and testes of case 7. For DNA extraction, tissue samples (30–50 mg) were physically disrupted using a TissueLyser II homogenizer (Qiagen, Hilden, Germany) by high-speed shaking in plastic tubes with stainless steel beads (5 mm in diameter). Genomic DNA was then extracted from the disrupted tissues with an AllPrep DNA/RNA Mini kit (Qiagen) according to the manufacturer’s instructions.

The PCR products were analyzed by electrophoresis on 2% agarose gel containing GelRed (Biotium, Fremont, California, USA), compared with molecular weight markers and subsequently photographed on a Gel-Doc UV transilluminator system (Bio-Rad, Hercules, California, USA).

Serological tests for brucellosis

Serum, cerebrospinal fluid and aqueous humor from case 5, and serum from cases 6 and 8, were tested by rapid serum agglutination (Rose Bengal plate test, RBT) using RBT antigen produced from B. abortus strain S99 [24, 50] to detect anti-smooth Brucella spp. antibodies. For case 8, the test was performed on a fresh sample, while for cases 6 and 8 was carried on thawed sera.

Whole genome sequencing and bioinformatics

Total genomic DNA of eight samples, from the cases studied with the following ID numbers 31957, 2780, 3838, 17753, 1259 and 25153, was sequenced using the Illumina NextSeq 500 platform. Briefly, the quantity of total DNA was measured with the Qubit fluorometer (QubitTM DNA HS assay; Life Technologies, Thermo Fisher Scientific, Inc.). The libraries were prepared using the Nextera XT library preparation kit (Illumina Inc., San Diego, CA) following the manufacturer’s instructions and the libraries were sequenced using NextSeq 500/550 Mid Output Reagent Cartridge v2 with 300 cycles generating 150 bp paired-end reads. Reads shorter than 70 bp and average Phred mean quality < 24 were automatically discarded. Raw reads were quality assessed using FastQC and trimmed to remove nucleotides with quality score less than 20 from 5′ end and 3′ end. Read coverage ranged from 29X to 113X, with an average of 63X.

Genomes were assembled using SPAdes version 3.11.1. and the scaffolds were used to assign MLST profiles using mlst tool (https://github.com/tseemann/mlst) which incorporates components of PubMLST database (https://pubmlst.org).

Sequence reads were deposited in Sequence Read Archive (SRA) database under NCBI Bioproject PRJNA623338.

Two samples, 10759 and 28753, were sequenced using IonTorrent platform and full genomes were assembled with Velvet 1.1.0 and deposited in NCBI with RefSeq Accession Numbers GCF_000590795.1 and GCF_000590815.1, respectively [42]. Additional 51 B. ceti and B. pinnipedialis WGS sequences available from the public database GenBank or Sequence Read Archive (SRA) were also included in the analysis. The dataset was limited to non-identical sequences that mapped to the B. ceti reference genome with less than 500 ambiguous matches (GenBank Accession Numbers NC_022905.1; NC_022906.1). SNP analysis was performed using In Silico Genotyper (ISG) version 0.16.10–3[55] using BWA-MEM (version 0.7.12-r1039) [56] as the aligner and GATK (version 3.9) [57] as a SNP caller. B. ceti genome (GenBank Accession Numbers NC_022905.1; NC_022906.1) was used as a reference. Default filters were applied to remove SNPs from duplicated regions, from regions with read coverage of less than 10X and with base call proportion less than 90%. Concatenated unique variants were used to generate maximum likelihood tree using IQ-TREE (version 1.6.9) [58, 59]. Ascertainment bias correction option was used to correct the branch lengths for the absence of constant sites in the SNP alignment. ModelFinder was used to select the best fit model and based on Bayesian Information Criterion (BIC) value and TVM+F+R2 model was chosen for phylogenetic reconstruction. Branch support was assessed using non-parametric bootstrap with 500 bootstrap replicates.

The population structure was assessed using a Bayesian approach implemented in BAPS 6.0 software with the module hierarchical BAPS (hierBAPS), which examines the existence of subgroups within a population and predicts the placement of individual sequences into specific clusters [6062].

Results

Post-mortem and histopathological investigations were performed on seven of the eight animals with positive culture for B. ceti (cases 1, 2, 4, 5, 6, 7, 8). The main gross findings included a moderate parasitic infection by Phyllobothrium delphini and/or Monorygma grimaldi plerocercoids (5/7; 71,4%), lymphadenomegaly (3/7; 42,8%), parasitic bronchopneumonia (3/7; 42,8%) and meningeal hyperaemia (3/7; 42,8%), which is regarded as the only macroscopic Brucella spp.-related lesion (cases 1, 4, 8) (Table 1).

Table 1. Brucella ceti-infected striped dolphins: stranding data, body condition, most significant findings (gross and microscopic), bacteriological, molecular and serological Brucella spp. investigations results, along with coinfections and the most probable cause of death.

Case no. ID strain Place, coordinates, date and stranding condition DC Sex Age NS Main pathological findings (macro/micro) ** B. ceti isolation*** Molecular detection of Brucella spp *** RBT Coinfections Most probable cause of death
1 10759 Gallipoli, (39.58 N, 18.00 E) March 11th-2012 found dead 2 Ma Ju Mo moderate parasitic infection by Phyllobothrium delphini and Monorygma grimaldi plerocercoids; meningeal hyperaemia; cerebral edema; pulmonary edema; non-suppurative leptomeningitis CNS-spleen NP NP severe cerebral impairment, associated to a primary B. ceti infection.
2 28753 Porto Cesareo*, October 2nd-2012 found dead 3 Fe Ju Go hepatocyte vacuolar degeneration; generalized lymphoid depletion; non-suppurative meningitis CNS NP NP severe cerebral impairment, associated to a primary B. ceti infection.
3 31957 Otranto*, November 13th -2013 found dead ND ND ND ND data not available CNS NP NP ND
4 2780 Porto Cesareo*, December 9th -2014 found dead ND Ma Ju Mo meningeal hyperemia; cerebral edema; marked lymphomonocytic meningitis (+++ medulla oblongata), lymphomonocytic plexocoroiditis, perivascular mononuclear cuffing; non-suppurative meningoencephalitis CNS NP NP severe cerebral impairment by a B. ceti infection
5 3838 Savona, 44.94 N, 8.18 E), February 15th -2017 found dead 2 Ma Ju Po moderate parasitic infection by Phyllobothrium delphini and Monorygma grimaldi plerocercoids; ulcerative glossitis; skin ulcers; splenic and prescapular lymphadenomegaly; bronchointerstitial pneumonia; multicentric lymphoid necrosis (spleen, PSC and PUL lymph nodes, laryngeal tonsil); multifocal necrotizing hepatitis; interstitial nephritis; non-suppurative meningoencephalitis CNS-spleen- lung- PSC ln-CSF CNS-spleen-lung, liver, PSC-TB-PUL ln tongue and skin ulcers- laryngeal tonsil-CSF Neg (CSF, AH, S) DMV T. gondii severe cerebral impairment, associated to a coinfection (DMV, T. gondii, B. ceti)
6 17753 Ardore, (38.11 N, 16.12 E) May 12th -2017 found dead 2 Fe Ad Go moderate parasitic infection by Phyllobothrium delphini and Monorygma grimaldi plerocercoids; severe parasitic bronchopneumonia; parasitic gastritis; non-suppurative meningoencephalitis CNS, spleen, LNs, liver, lung CNS Neg (S) DMV severe cerebral impairment, associated to a coinfection (DMV, B. ceti)
7 1259 Maruggio, (40.17 N, 17.35 E) December 6th– 2017 found dead 2 Ma Ju Po moderate parasitization by Phyllobothrium delphini and Monorygma grimaldi plerocercoids; moderate parasitic bronchopneumonia; multicentric reactive lymphadenopathy; moderate hepatocyte vacuolar degeneration; moderate multifocal bronchointerstitial pneumonia; mild multifocal mononuclear myocardial infiltrate; cerebral haemorrhages; severe non-suppurative meningoencephalitis CNS-spleen-liver-lung-kidney-testes CNS, spleen, liver, lung, kidney, testes NP DMV severe cerebral impairment, associated to a coinfection (DMV, B. ceti)
8 25153 Manduria, (40.18 N, 17.0 E) November 5th– 2018 found dead 2 Ma Ju Mo moderate parasitization by Phyllobothrium delphini plerocercoids; hemothorax and hemoperitoneum; generalized congestion; multicentric reactive lymphadenopathy; epicardial petechiae; mild parasitic bronchopneumonia; hemorrhagic parasitic gastritis; severe necrotizing enteritis; meningeal hyperaemia; non-suppurative meningoencephalitis CNS-lung-liver-kidney-spleen-MES ln NP Pos (S) DMV severe cerebral impairment, associated to a coinfection (DMV, B. ceti)

*: coordinates not available. DC, decomposition code (2, fresh; 3, moderate autolysis); Ma, male; Fe, female; Ad: adult; Ju: juvenile; NS, nutritional status; Mo, moderate; Po, poor; ND, not determined; NP, not performed; Neg, negative; Pos, positive; CNS: central nervous system; PSC ln, prescapular lymph node; TB ln, tracheo-bronchial lymph node; PUL ln, pulmonary lymph node; MES ln, mesenteric lymph node; LNs, lymph nodes; CSF, cerebrospinal fluid; AH, aqueous humor; S, serum; RBT, rosa bengala test; DMV, Dolphin Morbillivirus.

**Brucella-associated pathological features are shown in bold.

***Tissues positive are shown in bold.

The main microscopic findings were: non-suppurative meningoencephalitis (5/7; 71,4%); non-suppurative meningitis/leptomeningitis (2/7; 28,5%); multicentric lymphoid reactive hyperplasia (2/7; 28,5%); bronchointerstitial pneumonia (2/7; 28,5%); hepatocyte vacuolar degeneration (2/7; 28,5%); parasitic gastritis (2/7; 28,5%). Non-suppurative meningitis and/or meningoencephalitis, involving a mononuclear cell infiltration, observed in cases 1, 2, 4, 6, 7, 8, along with lymphoid necrosis and necrotizing hepatitis in case 5, were considered Brucella-type lesions (Table 1).

Moreover, protozoan cysts were apparent in the brain tissue of case 5 (S1 Table).

The microscopical features of B. ceti-associated CNS lesions are shown in Fig 2.

Fig 2. B. ceti-associated lesions in central nervous system of striped dolphins (S. coeruleoalba).

Fig 2

(A) Severe non-suppurative meningitis. Cerebellar meninges are infiltrated by mononuclear cells (case 2). 10x. H&E. Left upper inset: detail of the lympho-monocytic inflammatory infiltrate. 40x. H&E. (B) Severe non-suppurative meningitis (case 4). Meninges at the level of medulla oblongata are infiltrated by lympho-monocytic cells. 10x. H&E. (C) Mild non-suppurative meningoencephalitis (case 5). Chorioid plexuses are infiltrated by lympho-monocytic cells. 40x. H&E. (D) Mild non-suppurative meningoencephalitis (case 6). cerebellar meninges are infiltrated by mononuclear cells. 10x. H&E. Left upper inset: perivascular cuff characterized by the presence of lympho-monocytic cells. 20x. H&E. (E) Non-suppurative meningitis (case 7). Cerebral cortex meninges are infiltrated by mononuclear cells. 10x. H&E. (F) Non-suppurative meningitis (case 8). Meninges at the level of parietal cortex are infiltrated by mononuclear cells. 20x. H&E.

B. ceti was isolated from CNS of all the studied dolphins, while spleen was positive only in cases 1 and 5, and lung in case 5. The PCR for Brucella spp. detection directly from tissues resulted positive from CNS in case 5 and 6, in two out the three animals investigated, and from six different body sites in only one case (Table 1). On the contrary, the case 7 showed negative results from all the tissues tested.

The RBT test did not detect anti-Brucella antibodies in samples from cases 5 and 6, while resulted positive in the serum of the case 8 (Table 1).

Cases 6, 7 and 8 showed the coinfection by B. ceti and DMV and case 5 demonstrated the coinfection by B. ceti, DMV and T. gondii. Specifically, the animal showed anti-T.gondii and anti-DVM antibodies along with positive IHC and PCR tests from different tissues.

A full description of gross and microscopic findings observed, along with complete analytical data and considerations about the cause of death and the pathogenic role of B. ceti infection for each case considered are available in the S1 Table.

The genotyping of B. ceti using MLST classified the 8 strains as sequence type 26 (ST-26). The publicly available B. ceti and B. pinnipedialis genomes were assigned to the STs 23, 24, 25, 26 and 27.

The SNP analysis revealed 6,320 putative polymorphisms. The mapping of sequences to the reference ranged between 92% and 99%, with an average of 98%. The constructed phylogeny revealed that the population was divided into two major clades. As shown in Fig 3, the BAPS analysis split our dataset further into five groups based on the secondary level of clustering. Groups were monophyletic, confirming the robustness of the major branches of the SNP phylogeny, which were also supported by 100% bootstrap scores.

Fig 3. Maximum likelihood tree of B. ceti and B. pinnipedialis.

Fig 3

The tree was constructed using concatenated SNP sequences of 59 isolates and mid-point rooted. The branch colours correspond to BAPS populations and the major branches are labelled with bootstrap values.

The SNP analysis demonstrated that the clades comprising the ST-23, ST-27, corresponded to BAPS1 and BAPS2 groups while the ST-24 and ST-25 were included in the BAPS3 and the ST-26 was further subdivided into 2 groups (BAPS4 and BAPS5). The BAPS1 group comprised strains from the B. ceti species which contained mostly strains isolated from porpoises. BAPS2 group was composed of two strains from B. ceti ST-27, one of which was isolated from a human in New Zealand and the second from a dolphin in Croatia. The BAPS3 was composed of strains from the B. pinnipedialis species. The isolates from ST-26 were split into two subpopulations belonging to two different geographical areas with BAPS4 isolated in Costa Rica and BAPS5 isolated in the European Atlantic Sea and in the Mediterranean Sea. Interestingly, BAPS4 and BAPS5 contained mostly isolates from dolphins.

Whole genome SNP analysis showed that the strains from Italy were divided further into two genetically distinct subclades. The first subclade comprised exclusively the isolates from Ionian and Adriatic seas, while the second one included the strains from the Ligurian Sea and the Catalonian coast (Fig 3). Plotting these clades onto the geographic map suggests a link between their phylogeny and topographical distribution.

Discussion

To our knowledge, this study represents the first survey of B. ceti infection in striped dolphins from Italian waters and the first extensive characterization of B. ceti isolates reported to date.

The isolation of B. ceti was achieved from the CNS of all the dolphins under investigation. Only in two cases the isolation was obtained also from the other tissues (specifically spleen for case 1 and spleen and lung for case 5).

Although we observed several not pathognomonic signs, we detected specific gross pathological findings associated with Brucella infection, represented by hyperaemia of the meninges [9, 11] in three animals (cases 1, 4, 8).

No lesions were detected in the reproductive organs, and no signs associated with a potential abortion were found in the only adult female sampled (case 6).

A correlation between the infection and the pathological microscopic changes was observed in all cases submitted to histopathological investigations (neurobrucellosis, associated in one case with hepatic and lymph node necrosis). Specifically, non-suppurative meningitis or meningoencephalitis were detected in the CNS of 7 B. ceti-infected animals, thereby recapitulating the features of neurobrucellosis observed in humans [21, 22], as well as in striped dolphins elsewhere [9, 11, 19, 2326].

We detected severe coinfections in half of the animals investigated (cases 5, 6, 7, 8), involving DMV in all cases and T. gondii in case 5, as reported before for several cetacean species infected by Brucella spp. and Cetacean Morbillivirus [63] or T. gondii [26].

Considering the role of B. ceti infection in the striped dolphins under study, in cases 1, 2 and 4 the stranding could have resulted from a severe cerebral impairment, associated with severe brain inflammation caused by B. ceti infection.

Moreover, in case 2, the finding of a generalized lymphoid depletion, described before in dolphins with brucellosis [18, 64], suggests an immunocompromised host response, though the evidence of hepatocyte vacuolar degeneration could additionally make the effects of toxic environmental pollutants and/or an undisclosed viral infection other than DMV plausible.

The cause of death could not be hypothesized for case 3, considering the limited data available.

In cases 5, 6, 7 and 8 the stranding could have resulted from a severe cerebral impairment, associated with a coinfection by B. ceti and DMV, and, for case 5, also T. gondii. Noteworthy, in case 5, a striped dolphin in a poor body condition, the systemic spread of B. ceti infection, the evidence of additional Brucella-type lesions (multicentric lymphoid necrosis and multifocal necrotizing hepatitis), with the absence of anti-Brucella spp. antibodies and negative bacteriological and biomolecular results in CSF, suggests an acute fatal brucellosis infection that appears to be the most likely contributing cause of death. DMV and T. gondii infections, associated with typical pathological findings, represented respectively by bronchointerstitial pneumonia and protozoan cysts at cerebral level, along with specific immunopositivity and the presence of antibodies for both agents, may indeed support the potentially relevant role played by DMV and T. gondii in initiating the animal’s decline.

Interestingly, the anti-Brucella spp. antibodies observed in case 8 represent the only positive result among the three tested animals. The limited number of samples hampers any conclusion on the use of RBT for the detection of Brucella infection in dolphins. Nevertheless, the fact that the positive result was obtained by testing a fresh serum sample collected from an animal in a good conservation code, supports a true positive result [11]. Moreover, the negative serological findings are supported by the simultaneous detection of other antibodies in case 5 and a supposed immunocompromised host response in case 6, in presence of a widespread DMV infection. RBT test, while generally considered consistent, may produce false results due to variety of factors [65]. Therefore, in order to screen the immunological status of the examined animals, other serological tests such as ELISA could be used, as previously shown [66]. Although some discrepancies between results of RBT and ELISA tests have been reported, ELISA tests, such as iELISA have been successfully used to detect anti-Brucella antibodies in odontocetes and arctic wildlife [65, 66] and could therefore serve as a complementary method serological response to B. ceti in dolphins. The highest frequency of B. ceti infection was confirmed in juveniles. This observation seems to be in discordance with a study performed in striped dolphins stranded in Costa Rica [64], in which meningoencephalomyelitis was revealed in the same number of juveniles and adults that displayed neurological syndromes before death, as well as with a previous study in marine mammals stranded in Brazil [18]. Specifically, in a population made up of several cetacean species, the highest frequency of Brucella spp. infection was confirmed in the newborn calves, whereas, within the genus Stenella, the most commonly infected age-group were the adults.

None of the cases considered in this report stranded alive, so it was not possible to observe neurological symptoms at the time of stranding.

The genomic analysis of the B. ceti strains isolated from the stranded dolphins grouped them into the common ST-26 in agreement with the previous reports [28]. The whole genome SNP analysis showed that the population was divided into 5 main groups, one of which included the B. pinnipedialis species while the remaining four were assigned to B. ceti. It is interesting to note how these groups identify specific STs in accordance with the MLST which therefore allows us to use previous data as a legacy to give consistency to the host spectrum as well as to geographic location. According to these data, we observed that the BAPS1 from B. ceti and BAPS3 from B. pinnipedialis, although not exclusively, are mainly found in porpoises and seals. Similar cluster partition was observed previously with MLVA data, which demonstrated the existence of the B. ceti group, predominantly associated with porpoises [28]. Their geographical location, instead, appeared to be linked to the Atlantic Ocean, even though the real distribution could be wider.

On the other hand, the BAPS 2, 4 and 5 populations seemed to be mainly observed in dolphins. The more consistent groups, BAPS4 and BAPS5, which belonged to the ST-26, were further divided from a geographical point of view and split the of Costa Ricans strains from those of the Mediterranean and the Atlantic Ocean. Further analysis revealed that the BAPS5 population was divided into geographically separated subgroups. The phylogeographic division found for these strains resembled the phylogeographic evolution of the striped dolphin [67]. The evolution of the striped dolphin suggests that its population is divided between the eastern and western Mediterranean, thus confirming the genomic division between B. ceti strains from the Ligurian Sea and the Adriatic and Ionian Seas observed in our analysis.

The data obtained by whole genome SNP analysis suggest an interesting relationship between phylogeny and geographical distribution of B. ceti strains in Italy, therefore providing new insights into the phylogenetic structure of B. ceti in the Mediterranean. Nevertheless, further studies from the Mediterranean Sea are required to elucidate the molecular evolution of B. ceti and its actual distribution.

In summary, our results provide novel data and pathological evidence of B. ceti infection in cetacean species in Italy, and the geographic distribution range of this agent in Italian waters. Considering the results of this survey and the other data available [16, 26], the occurrence of B. ceti infection in cetaceans stranded, along the Italian coastline appears to be limited to specific areas (Liguria, Tuscany, Apulia, Calabria), with the highest occurrence of B. ceti infected cetaceans along the Ionian coastline, which suggests consistent circulation of the bacterial pathogen in that area. Our results highlight the need for continuous surveillance and monitoring studies to better understand the pathogen, host and environmental factors involved in cetacean Brucella spp. infection’s epidemiology, in tight agreement with the “One Health” concept. WGS typing proved to be useful for molecular classification of B. ceti strains and allowed the typing of large populations. The genetic clustering based on SNP analysis was in agreement with all previously reported methods and additionally it provided a much higher discriminatory power.

The severity of B. ceti-associated lesions reported in the present study supports the role of this microbial agent as a primary neurotropic pathogen in striped dolphins, as well as a probable cause of stranding events and death, as previously described elsewhere [14]. In this regard, our results corroborate previous reports indicating striped dolphins as highly susceptible hosts for developing neurobrucellosis in comparison with the other cetaceans [64], thus confirming neurobrucellosis as one of the most significant lesions’ pattern associated to B. ceti infection [26, 64, 68].

Additional studies are required to identify the mechanisms involved in the crossing of the blood-brain barrier and the pathogen and host-related factors driving B. ceti neuroinvasion, colonization and persistence in the CNS [27]. Moreover, a detailed understanding of the effects of pollutant-related immunotoxicity on pathogenicity of B. ceti, as suggested by some case reports [16, 69], is required, particularly in light of conflicting result obtained using ex vivo model [70].

Surveillance of strandings in Italy involves organisations from governmental and academic institutions with different areas of expertise such as public health, animal health and environment. Such network made our study possible, and our findings highlight the importance of the multidisciplinary approach in the monitoring of stranded cetaceans, with epidemiological data and laboratory information truly shared across sectors in the perspective of the one-health approach.

Finally, based on the demonstrated zoonotic capability of B. ceti [31, 32, 33], proper handling of stranded animals, together with an ad hoc adoption of all necessary biosafety and biosecurity measures and protocols during post mortem and diagnostic investigations on stranded cetaceans are strongly recommended to avoid the risk of transmission to humans of this and other zoonotic pathogens.

Supporting information

S1 Table. Full description of gross and microscopical findings, associated with complete diagnostic test results and the most likely cause of death for each case considered.

(DOCX)

Data Availability

The WGS data is submitted at NCBI GenBank with the following accession number: PRJNA623338.

Funding Statement

This work was supported by the Italian Ministry of Health. WM received funding from the Italian Ministry of Health under gran agreement code IZSPLV 09/18. GG received funding from the Italian Ministry of Health under gran agreement code IZSAM 02/17 RC. The funder had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.

References

  • 1.Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents. 2010. November 36 Suppl 1: S8–11. 10.1016/j.ijantimicag.2010.06.013 [DOI] [PubMed] [Google Scholar]
  • 2.Corbel MJ. Brucellosis in humans and animals. World Health Organization. 2006. https://apps.who.int/iris/handle/10665/43597
  • 3.Ewalt DR, Payeur JB, Martin BM, Cummins DR, Miller WG. Characteristics of a Brucella species from a bottlenose dolphin (Tursiops truncatus) J Vet Diagn Invest. 1994; 6:448–452 10.1177/104063879400600408 [DOI] [PubMed] [Google Scholar]
  • 4.Ross HM, Foster G, Reid RJ, Jahans KL, MacMillan AP. Brucella species infection in sea-mammals. Vet Rec. 1994; 134(14): 359 10.1136/vr.134.14.359-b [DOI] [PubMed] [Google Scholar]
  • 5.Foster G, Osterman BS, Godfroid J, Jacques I, Cloeckaert A. Brucella ceti sp. nov. and Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int J Syst Evol Microbiol. 2007. November;57(Pt 11):2688–93. 10.1099/ijs.0.65269-0 [DOI] [PubMed] [Google Scholar]
  • 6.Miller WG, Adams LG, Ficht TA, Cheville NF, Payeur JP, Harley DR, et al. Brucella-induced abortions and infection in bottlenose dolphins (Tursiops truncatus). J Zoo Wildl Med. 1999. March; 30(1):100–10. [PubMed] [Google Scholar]
  • 7.Foster G, MacMillan AP, Godfroid J, Howie F, Ross HM, Cloeckaert A, et al. A review of Brucella sp. infection of sea mammals with particular emphasis on isolates from Scotland. Vet Microbiol. 2002. December 20; 90(1–4):563–80. 10.1016/s0378-1135(02)00236-5 [DOI] [PubMed] [Google Scholar]
  • 8.Ohishi K, Zenitani R, Bando T, Goto Y, Uchida K, Maruyama T, et al. Pathological and serological evidence of Brucella-infection in baleen whales (Mysticeti) in the western North Pacific. Comp Immunol Microbiol Infect Dis. 2003. March; 26(2):125–36. 10.1016/s0147-9571(02)00036-x [DOI] [PubMed] [Google Scholar]
  • 9.González-Barrientos R, Morales JA, Hernández-Mora G, Barquero-Calvo E, Guzmán-Verri C, Chaves-Olarte E, et al. Pathology of striped dolphins (Stenella coeruleoalba) infected with Brucella ceti. J Comp Pathol. 2010. May;142(4):347–52. 10.1016/j.jcpa.2009.10.017 [DOI] [PubMed] [Google Scholar]
  • 10.Nymo HI, Tryland M, Godfroid J. A review of Brucella infection in marine mammals, with special emphasis on Brucella pinnipedialis in the hooded seal (Cystophora cristata). Vet Res. 2011; 42(1): 93 10.1186/1297-9716-42-93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Guzmán-Verri C, González-Barrientos R, Hernández-Mora G, Morales JA, Baquero-Calvo E, Chaves-Olarte E, et al. Brucella ceti and Brucellosis in Cetaceans Front Cell Infect Microbiol. 2012; 2: 3 10.3389/fcimb.2012.00003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sierra E, Sánchez S, Saliki JT, Blas-Machado U, Arbelo M, Zucca D, et al. Retrospective study of etiologic agents associated with nonsuppurative meningoencephalitis in stranded cetaceans in the Canary Islands. J Clin Microbiol. 2014. July;52(7):2390–7. 10.1128/JCM.02906-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Olsen SC, Palmer MV. Advancement of knowledge of Brucella over the past 50 years. Vet Pathol. 2014. November;51(6):1076–89. 10.1177/0300985814540545 [DOI] [PubMed] [Google Scholar]
  • 14.Isidoro-Ayza M, Ruiz-Villalobos N, Pérez L, Guzmán-Verri C, Muñoz PM, Alegre F, et al. Brucella ceti infection in dolphins from the Western Mediterranean sea. BMC Vet Res. 2014. September 17; 10:206 10.1186/s12917-014-0206-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Colegrove KM, Venn-Watson S, Litz J, Kinsel MJ, Terio KA, Fougeres E, et al. Fetal distress and in utero pneumonia in perinatal dolphins during the Northern Gulf of Mexico unusual mortality event. Dis Aquat Organ. 2016. April 12;119(1):1–16. 10.3354/dao02969 [DOI] [PubMed] [Google Scholar]
  • 16.Grattarola C, Giorda F, Iulini B, Pintore MD, Pautasso A, Zoppi S, et al. Meningoencephalitis and Listeria monocytogenes, T. gondii and Brucella spp. coinfection in a dolphin in Italy. Dis Aquat Organ. 2016. February 25;118(2):169–74. 10.3354/dao02957 [DOI] [PubMed] [Google Scholar]
  • 17.Davison NJ, Perrett LL, Dawson C, Dagleish MP, Haskins G, Muchowski J, et al. Brucella ceti Infection in a Common Minke Whale (Balaenoptera acutorostrata) with Associated Pathology. J Wildl Dis. 2017. July;53(3):572–576. 10.7589/2016-08-200 [DOI] [PubMed] [Google Scholar]
  • 18.Sánchez-Sarmiento AM, Carvalho VL, Díaz-Delgado J, Ressio RA, Fernandes NCCA, Guerra JM, et al. Molecular, serological, pathological, immunohistochemical and microbiological investigation of Brucella spp. in marine mammals of Brazil reveals new cetacean hosts. Transbound Emerg Dis. 2019. July;66(4):1674–1692. 10.1111/tbed.13203 [DOI] [PubMed] [Google Scholar]
  • 19.Bossart GD. Marine Mammals as Sentinel Species for Oceans and Human Health. Vet Pathol. 2011; 48(3): 676–690. 10.1177/0300985810388525 [DOI] [PubMed] [Google Scholar]
  • 20.Hernández-Mora G, Palacios-Alfaro JD, González-Barrientos R. Wildlife reservoirs of brucellosis: Brucella in aquatic environments. Rev Sci Tech. 2013. April;32(1):89–103. 10.20506/rst.32.1.2194 [DOI] [PubMed] [Google Scholar]
  • 21.Shakir RA, Al-Din AS, Araj GF, Lulu AR, Mousa AR, Saadah MA. Clinical categories of neurobrucellosis. A report on 19 cases. Brain. 1987. February;110 (Pt 1):213–23. [DOI] [PubMed] [Google Scholar]
  • 22.Obiako OR, Ogoina D, Danbauchi SS, Kwaifa SI, Chom ND, Nwokorie E. Neurobrucellosis—a case report and review of literature. Niger J Clin Pract. 2010. September;13(3):347–50. [PubMed] [Google Scholar]
  • 23.González L, Patterson IA, Reid RJ, Foster G, Barberán M, Blasco JM, et al. Chronic meningoencephalitis associated with Brucella sp. Infection in live-stranded striped dolphins (Stenella coeruleoalba). J Comp Pathol. 2002. Feb-Apr;126(2–3):147–52. 10.1053/jcpa.2001.0535 [DOI] [PubMed] [Google Scholar]
  • 24.Hernández-Mora G, González-Barrientos R, Morales JA, Chaves-Olarte E, Guzmán-Verri C, Barquero-Calvo E, et al. Neurobrucellosis in stranded dolphins, Costa Rica. Emerg Infect Dis. 2008. September;14(9):1430–3. 10.3201/eid1409.071056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Davison NJ, Cranwell MP, Perrett LL, Dawson CE, Deaville R, Stubberfield EJ, et al. Meningoencephalitis associated with Brucella species in a live-stranded striped dolphin (Stenella coeruleoalba) in south-west England. Vet Rec. 2009. July 18;165(3):86–9. 10.1136/vetrec.165.3.86 [DOI] [PubMed] [Google Scholar]
  • 26.Alba P, Terracciano G, Franco A, Lorenzetti S, Cocumelli C, Fichi G, et al. The presence of Brucella ceti ST26 in a striped dolphin (Stenella coeruleoalba) with meningoencephalitis from the Mediterranean Sea. Vet Microbiol. 2013. May 31;164(1–2):158–63. 10.1016/j.vetmic.2013.01.023 [DOI] [PubMed] [Google Scholar]
  • 27.Di Guardo G, Centelleghe C, Mazzariol S. Cetacean Host-Pathogen Interaction(s): Critical Knowledge Gaps. Front Immunol. 2018. November 28; 9:2815 10.3389/fimmu.2018.02815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Maquart M, Le Flèche P, Foster G, Tryland M, Ramisse F, Djønne B, et al. MLVA-16 typing of 295 marine mammal Brucella isolates from different animal and geographic origins identifies 7 major groups within Brucella ceti and Brucella pinnipedialis. BMC Microbiol. 2009. July 20;9:145 10.1186/1471-2180-9-145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Suárez-Esquivel M, Baker KS, Ruiz-Villalobos N, Hernández-Mora G, Barquero-Calvo E, González-Barrientos R et al. Brucella Genetic Variability in Wildlife Marine Mammals Populations Relates to Host Preference and Ocean Distribution, Genome Biol Evol. 2017. July 9; 7: 1901–1912, 10.1093/gbe/evx137 10.1093/gbe/evx137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rhyan JC, Gidlewski T, Ewalt DR, Hennager SG, Lambourne DM, Olsen SC. Seroconversion and abortion in cattle experimentally infected with Brucella sp. isolated from a Pacific harbor seal (Phoca vitulina richardsi). J Vet Diagn Invest. 2001. September;13(5):379–82. 10.1177/104063870101300502 [DOI] [PubMed] [Google Scholar]
  • 31.Sohn AH, Probert WS, Glaser CA, Gupta N, Bollen AW, Wong JD, et al. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis. 2003. April;9(4):485–8. 10.3201/eid0904.020576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.McDonald WL, Jamaludin R, Mackereth G, Hansen M, Humphrey S, Short P, et al. Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol. 2006. December;44(12):4363–70. 10.1128/JCM.00680-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Brew SD, Perrett LL, Stack JA, MacMillan AP, Staunton NJ. Human exposure to Brucella recovered from a sea mammal. Vet Rec. 1999. April 24;144(17):483 [PubMed] [Google Scholar]
  • 34.Whatmore AM, Perret LL, MacMillan AP. Characterisation of the genetic diversity of Brucella by multilocus sequencing. BMC Microbiol, 2007. April 20; 7: 34 10.1186/1471-2180-7-34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Whatmore AM, Dawson CE, Grossaud P, Koylass MS, King AC, Shankster SJ et al. Marine Mammal Brucella genotype associated with zoonotic infection. Emerg Infect Dis. 2008. March; 14 (3):517–8. 10.3201/eid1403.070829 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Van Bressem MF, Van Waerebeek K, Raga JA, Godfroid J, Brew SD, MacMillan AP. Serological evidence of Brucella species infection in odontocetes from the south Pacific and the Mediterranean. Vet Rec. 2001. May 26;148(21):657–61. 10.1136/vr.148.21.657 [DOI] [PubMed] [Google Scholar]
  • 37.Profeta F, Di Francesco CE, Marsilio F, Mignone W, Di Nocera F, De Carlo E, et al. Retrospective seroepidemiological investigations against Morbillivirus, T. gondii and Brucella spp. in cetaceans stranded along the Italian coastline (1998–2014). Res Vet Sci. 2015. August;101:89–92. 10.1016/j.rvsc.2015.06.008 [DOI] [PubMed] [Google Scholar]
  • 38.Garofolo G, Zilli K, Troiano P, Petrella A, Marotta F, Di Serafino G, et al. Brucella ceti from two striped dolphins stranded on the Apulia coastline, Italy. J Med Microbiol. 2014. February;63(Pt 2):325–9. 10.1099/jmm.0.065672-0 [DOI] [PubMed] [Google Scholar]
  • 39.Whatmore AM, Dawson CE, Grossaud P, Koylass MS, King AC, Shankster SJ, et al. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol. 2009. December;9(6):1168–84. 10.1016/j.meegid.2009.07.001 [DOI] [PubMed] [Google Scholar]
  • 40.Cvetnić Ž, Duvnjak S, Đuras M, Gomerčić T, Reil I, Zdelar-Tuk M et al. Evidence of Brucella strain ST27 in bottlenose dolphin (Tursiops truncatus) in Europe. Vet Microbiol. 2016. November 30; 196:93–97. 10.1016/j.vetmic.2016.10.013 [DOI] [PubMed] [Google Scholar]
  • 41.Duvnjak S, Špičić S, Kušar D, Papić B, Reil I, Zdelar-Tuk M, et al. Whole-Genome Sequence of the First Sequence Type 27 Brucella ceti Strain Isolated from European Waters. Genome Announc. 2017. September 14;5(37). pii: e00988-17. 10.1128/genomeA.00988-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ancora M, Marcacci M, Orsini M, Zilli K, Di Giannatale E, Garofolo G, et al. Complete Genome Sequence of a Brucella ceti ST26 Strain Isolated from a Striped Dolphin (Stenella coeruleoalba) on the Coast of Italy. Genome Announc. 2014. March 6;2(2). pii: e00068-14. 10.1128/genomeA.00068-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Geraci JR & Lounsbury VJ. 2005. Marine Mammals Ashore: A Field Guide for Strandings (Second Edition) National Aquarium in Baltimore, Baltimore, MD. [Google Scholar]
  • 44.Pugliares KR, Bogomolni AL, Touhey KM, Herzig SM, Harry CT, Moore MJ. Small cetacean necropsy technique and anatomy. In: Marine mammal necropsy: An introductory guide for stranding responders and field biologists. Woods hole Oceanographic Institution Technical Report WHOI-2007-06, Woods Hole, Massachussets; 2007. pp. 53–55
  • 45.Anderson RC. Keys to the genera of the superfamily Metastrongyloidea In: CIH keys to the nematode parasites of vertebrates. No. 5. Anderson RC, Chabaud AG, Willmott S editors. Commonwealth Agricultural Bureaux, Farnham Royal, UK; Vol.5, 1978. pp.1–40 [Google Scholar]
  • 46.Khalil LF, Jones A, Bray RA. Keys to the Cestode Parasites of Vertebrates. CAB International, Wallingford, UK; 1994. 752 pp [Google Scholar]
  • 47.Pintore MD, Mignone W, Di Guardo G, Mazzariol S, Ballardini M, Florio CL et al. Neuropathologic findings in cetaceans stranded in Italy (2002–14). J Wildl Dis. 2018. April;54(2):295–303. 10.7589/2017-02-035 [DOI] [PubMed] [Google Scholar]
  • 48.Verna F, Giorda F, Miceli I, Rizzo G, Pautasso A, Romano A, et al. Detection of morbillivirus infection by RT-PCR RFLP analysis in cetaceans and carnivores. J Virol Methods. 2017. September;247:22–27. 10.1016/j.jviromet.2017.05.009 [DOI] [PubMed] [Google Scholar]
  • 49.Vitale M, Galluzzo P, Currò V, Gozdzik K, Schillaci D, Di Marco, et al. A high sensitive nested PCR for T. gondii detection in animal and food samples. J Microb Biochem Technol. 2013; 5: 39–41. [Google Scholar]
  • 50.Di Guardo G, Proietto U, Di Francesco CE, Marsilio F, Zaccaroni A, Scaravelli D, et al. Cerebral toxoplasmosis in striped dolphins (Stenella coeruleoalba) stranded along the Ligurian Sea coast of Italy. Vet Pathol. 2010. March;47(2):245–53. 10.1177/0300985809358036 [DOI] [PubMed] [Google Scholar]
  • 51.OIE Terrestrial Manual. Brucellosis (Brucella abortus, B. melitensis and B. suis) (infection with B. abortus, B. melitensis and B. suis. In: Manual of Diagnostic Tests and Vaccines for terrestrial animals. 2019. online version. Part 3. Chapter 3.1.4
  • 52.Alton GG, Jones ML, Angus RD, Verger JM. Techniques for the Brucellosis Laboratory. INRA: Paris; 1988
  • 53.Cloeckaert A, Verger J M, Grayon M, Grepinet O. Restriction site polymorphism of the genes encoding the major 25 kDa and 36 kDa outer membrane proteins of Brucella. Microbiology. 1995. September; 141: 2111–2121 10.1099/13500872-141-9-2111 [DOI] [PubMed] [Google Scholar]
  • 54.Baily GG, Krahn JB, Drasar BS, Stoker NG. Detection of Brucella melitensis and Brucella abortus by DNA amplification. J Trop Med Hyg. 1992. August;95(4):271–5. [PubMed] [Google Scholar]
  • 55.Sahl JK, Beckstrom-Sternberg SM, Babic-Sternberg JS, Gillece JD, Hepp CM, Auerbach RK et al. The In Silico Genotyper (ISG): an open-source pipeline to rapidly identify and annotate nucleotide variants for comparative genomics applications. 2015. bioRxiv preprint 10.1101/015578 [Google Scholar]
  • 56.Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv 2013 preprint arXiv:1303.3997
  • 57.Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013; 43:11.10.1–11.10.33. 10.1002/0471250953.bi1110s43 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015. January;32(1):268–74. 10.1093/molbev/msu300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017. June;14(6):587–589. 10.1038/nmeth.4285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Cheng L., Connor TR, Sirén J, Aanensen DM, Corander J. Hierarchical and Spatially Explicit Clustering of DNA Sequences with BAPS Software. Mol Biol Evol. 2013. May; 30(5): 1224–1228. 10.1093/molbev/mst028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Corander J, Waldmann P, Sillanpää MJ. Bayesian analysis of genetic differentiation between populations. Genetics. 2003. January;163(1):367–74 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Muñoz PM, Mick V, Sacchini L, Janowicz A, De Miguel M J, Cherfa MA et al. Phylogeography and epidemiology of Brucella suis biovar 2 in wildlife and domestic swine. Vet Microbiol. 2019; 233: 68–77. 10.1016/j.vetmic.2019.04.025 [DOI] [PubMed] [Google Scholar]
  • 63.West KL, Levine G, Jacob J, Jensen B, Sanchez S, Colegrove K, et al. Coinfection and vertical transmission of Brucella and Morbillivirus in a neonatal sperm whale (Physeter macrocephalus) in Hawaii, USA. J Wildl Dis. 2015. January;51(1):227–32. 10.7589/2014-04-092 [DOI] [PubMed] [Google Scholar]
  • 64.González-Barrientos R, Morales JA, Hernández-Mora G, Barquero-Calvo E, Guzmán-Verri C, Chaves-Olarte E, et al. Pathology of striped dolphins (Stenella coeruleoalba) infected with Brucella ceti. J Comp Pathol. 2010. May;142(4):347–52. 10.1016/j.jcpa.2009.10.017 [DOI] [PubMed] [Google Scholar]
  • 65.Hernández-Mora G, Manire CA, González-Barrientos R, Barquero-Calvo E, Guzmán-Verri C, Staggs L et al. Serological diagnosis of Brucella infections in odontocetes. Clin Vaccine Immunol. 2009. June;16(6):906–15. 10.1128/CVI.00413-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Nymo IH, Godfroid J, Åsbakk K, Larsen AK, da Neves CG, Rødven R et al. A protein A/G indirect enzyme-linked immunosorbent assay for the detection of anti-Brucella antibodies in Arctic wildlife. J Vet Diagn Invest. 2013. May;25(3):369–75. 10.1177/1040638713485073 [DOI] [PubMed] [Google Scholar]
  • 67.Gaspari S, Azzellino A, Airoldi S, Hoelzel AR. Social kin associations and genetic structuring of striped dolphin populations (Stenella coeruleoalba) in the Mediterranean Sea. Mol Ecol. 2007. July;16(14):2922–33. 10.1111/j.1365-294X.2007.03295.x [DOI] [PubMed] [Google Scholar]
  • 68.Muñoz M, García-Castrillo G, López-García P, González-Cueli JC, De Miguel MJ, Marín CM, et al. Isolation of Brucella species from a live-stranded striped dolphin (Stenella coeruleoalba) in Spain. Vet Rec. 2006. 158: 450–451. 10.1136/vr.158.13.450 [DOI] [PubMed] [Google Scholar]
  • 69.Davison NJ, Perrett LL, Law RJ, Dawson CE, Stubberfield EJ, Monies RJ et al. Infection with Brucella Ceti and High Levels of Polychlorinated Biphenyls in Bottlenose Dolphins (Tursiops Truncatus) Stranded in South-West England. Vet Rec. 2011. July; 2;169(1):14 10.1136/vr.d2714 [DOI] [PubMed] [Google Scholar]
  • 70.Nymo IH, das Neves CG, Tryland M, Bårdsen BJ, Santos RL, Turchetti AP et al. Brucella pinnipedialis hooded seal (Cystophora cristata) strain in the mouse model with concurrent exposure to PCB 153. Comp Immunol Microbiol Infect Dis. 2014. 37: 195–204. 10.1016/j.cimid.2014.01.005 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Roy Martin Roop II

21 May 2020

PONE-D-20-10982

Occurrence of Brucella ceti in striped dolphins from Italian Seas

PLOS ONE

Dear Dr. Grattarola,

Thank you for submitting your manuscript to PLOS ONE. Both reviewers expressed the opinion that the studies described in your paper were well done and that the information presented will be valuable to the field. However, both reviewers also pointed out issues that need to be addressed before the manuscript will be considered suitable for publication. Thus, I am going to ask that you submit a revised manuscript that appropriately addresses all of  the issues raised by both of  these reviewers.

We would appreciate receiving your revised manuscript by August 20, 2020. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript!

Sincerely,

R. Martin Roop II, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you are reporting an analysis of a microarray, next-generation sequencing, or deep sequencing data set. PLOS requires that authors comply with field-specific standards for preparation, recording, and deposition of data in repositories appropriate to their field. Please upload these data to a stable, public repository (such as ArrayExpress, Gene Expression Omnibus (GEO), DNA Data Bank of Japan (DDBJ), NCBI GenBank, NCBI Sequence Read Archive, or EMBL Nucleotide Sequence Database (ENA)). In your revised cover letter, please provide the relevant accession numbers that may be used to access these data. For a full list of recommended repositories, see http://journals.plos.org/plosone/s/data-availability#loc-omics or http://journals.plos.org/plosone/s/data-availability#loc-sequencing.

3. In your Methods section, please provide additional location information of the study sites, including geographic coordinates for the data set if available.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1.    You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: General comments

This is a very comprehensive study. However, some clarification is needed (see specific comments).

I would have like to see some comparison with MLVA results described in the manuscript. The PCR methods for identification could have been using another target (IS711) and/or be updated (qPCR).

About pathology, the authors should discuss abortion (they seem not to have seen).

The authors should mention that they did not sample in the Adriatic Sea. They should discuss that this may be one of the reasons why they did not report ST27.

Specific comments

L61: lesions are described in cetaceans not in pinnipeds, so change “marine mammals” accordingly.

L91: the first report on the isolation of B. ceti was in 1994. Do you mean first isolation in the Mediterranean sea?

L163: why were subcultures performed on Farrell’s media?

L196: outer membrane of Brucella spp., not B. abortus. Why did you not use the IS711 based PCR or even better qPCR?

L260: BAPS analysis (ref 57, 58) are not been used previously for Brucella. A short explanation is needed here.

L268-432: I am wondering if all the case descriptions are necessary. Perhaps Table 1, would be sufficient?

L463: which “other genomes”?

L537-538: please explain how these results are in agreement with MLVA results.

L556-557: please be more specific. An association between exposure to pollutants and higher exposure/infection rates in marine mammals has been suggested (you touch upon these things later in the manuscript).

L578: could you please explain to the prospective reader your multidisciplinary approach?

Reviewer #2: The manuscript by Garofolo and coworkers entitled “Occurrence of Brucella ceti in striped dolphins from Italian Seas” describes the pathological analysis of 8 cases of stranding of striped dolphins in the coasts of Italy. Several diagnostic tools are used in order to investigate cause of stranding, including macro and microscopic observations, histology, serology, molecular detection, bacterial isolation, parasites identification in target tissues according to literature. In the presented cases, bacterial cultures were positive for Brucella and results confirmed by WGS.

The study is methodological sound and the analysis is thorough.

The way data is presented could be improved, particularly to improve focus as follows:

1. Normalize the detail level of findings described. Although emphasis is given in Brucella ceti findings and characterization, there are other interesting findings related to the stranded dolphins that deserve attention. This should also be reflected in the materials and methods section, where description of protocols used to carry out the pathology study, parasites and worm identification as well as histological findings are need it.

2. Remove description of cases, and add it as a supplementary info. Description of each case can be improved connecting ideas instead of listing findings. Use table 1 to improve results section writing.

3. In the results section, indicate genome quality of the genomes analyzed, including depth coverage and percentage of mapping against reference genome. Were these criteria used in the selection of genomes to be included in the analysis.

4. Several possible cause of deaths are suggested for the different cases. Indicate how the authors arrived to the different conclusions indicated for each case.

5. Explain how the IonTorrent sequenced genomes were used in the presented work.

Minor points:

1. Introduction, page 10, lane 80: “The marine Brucella strains are classified into three major groups, with five clusters and 15 sequence 81 types (STs). Please explain what are the major groups and clusters and the context of this classification.

2. Materials and methods, page 13, lane 152: “ The CNS of the case 6 was submitted to isolation retrospectively, since histopathology findings of neurobrucellosis had been observed”. Not sure what is the message from this sentence; retrospectively means that was carried out after a long time has passed since the histopathology analysis?

3. Materials and methods, page 13, lane 162: " The enrichment cultures in broth media were weekly subcultured (six subcultures) on Farrell’s Agar medium. Suspect colonies were tested for Gram stain reaction as well as for catalase, oxidase and urease activities, motility and slide agglutination tests with Brucella polyvalent antiserum.” Differences in smooth and rough phenotype have being described after several passages in B. ceti isolates. Please indicate on what subculture the agglutination test was performed and specifically what Brucella polyvalent antiserum was used.

4. Materials and methods, page 15, lane 203: please specify the negative controls used. This is very important since the used PCR was not designed to detect Brucella specific amplicons in striped dolphins’ tissues.

5. Discussion, page 27, first lane: “To our knowledge, this study represents the first survey of B. ceti infection in cetaceans of Italian waters and the first extensive characterization of B. ceti isolates reported to date”. Cetaceans is a general group of marine mammals. The study refers to a deep analysis of B. ceti isolates from striped dolphins.

6. Discussion, page 27, lane 496 : “Considering the major gross and microscopical findings reported, many of the general pathological findings were not related to brucellosis.” This affirmation seems contradictory to the explanation that follows it. Please rephrase.

7. Discussion, page 28, lane 514: “Based on serological investigations, only one case (Case 8) of the three investigated (Cases 5, 6, 8) resulted positive for anti-Brucella spp. antibodies.” This observation deserves further discussion, since coinfections are relevant in the Mediterranean. Why only one positive for RBT? Causes? Sample degradation? Bacteria with rough phenotype? How is this related with the fact that the authors state that Brucella appears to be acting as a secondary pathogen in lane 519? Brucella has been considered a primary pathogen in most host species. If the authors consider that this is not the case in striped dolphins, this should be properly discussed.

8. Discussion, page 28, lane 521 and following: “The highest frequency of B. ceti infection was confirmed in juveniles (6 out of 7 cases with age determined), followed by adults (1 out of 7).” Comparison with the data from Brazil are not accurate since sample population is different, taking into account several cetacean species. A more accurate comparison can be done by comparing only striped dolphin’s data in the Brazil study, and recent Costa Rica and US studies.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Jacques Godfroid

Reviewer #2: Yes: Caterina Guzmán-Verri

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Oct 2;15(10):e0240178. doi: 10.1371/journal.pone.0240178.r002

Author response to Decision Letter 0


11 Aug 2020

Dear Reviewer 1,

We would like to thank you for giving us the opportunity to revise and resubmit this manuscript.

We answered to all general and specific comments, point by point, in the Response to Reviewers in attachment.

Overall, we have extensively edited the manuscript in order to avoid the descriptions of all the cases,

by a reorganization of the material methods and results sections, also creating a supplementary table, to normalize the detail level of findings in the text.

We hope that you will find that we have addressed all the concerns raised.

Dear Reviewer 2,

We would like to thank you for giving us the opportunity to revise and resubmit this manuscript.

We answered to all comments, point by point, in the Response to Reviewers in attachment.

Specifically, in order to normalize the detail level of findings described, we have extensively edited the manuscript avoiding the descriptions of all the cases,and we reorganized the material methods and results sections, also creating a supplementary table to give more details on the ancillary tests. Moreover, we revised in the conclusions about the possible cause of death suggested for the differents cases under study, and you may check it in the discussion section.

We have had one English speaker review the manuscript that has found this current version to be grammatically sound. I trust that the editing improved the manuscript.

We hope that you will find that we have addressed all the concerns raised.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Roy Martin Roop II

10 Sep 2020

PONE-D-20-10982R1

Occurrence of Brucella ceti in striped dolphins from Italian Seas

PLOS ONE

Dear Dr. Grattarola,

Both reviewers expressed the opinion that your revised manuscript is greatly improved, but they both also noted a few things that still need to be addressed. Their comments should be easy to address, and doing so will further improve the paper. Thus, I am going to ask that you submit a revised manuscript that addresses the points they raise.

Please submit your revised manuscript by December 9, 2020. However, I don't think that it will take very long to deal with the few points the reviewers have raised. But if  you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

I look forward to receiving the revised manuscript!

Sincerely,

Marty Roop

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have 1 comment that perhaps need an explanatory sentence and reference in the final manuscript.

Serology:

The RBT has limitations when used in wildlife species, particularly marine mammals. therefore ELISAs are excellent alternatives. More, a "universal" indirect ELISA for detecting antibodies in mammals, including marine mammals has been described and documented: Nymo I.H., Godfroid J., Asbakk K., Larsen A.K., das Neves C.G., Rødven R., Tryland M. 2013. A protein A/G indirect enzyme-linked immunosorbent assay for the detection of anti-Brucella antibodies in Arctic wildlife. J. Vet. Diagn. Invest., 25: 369-375. doi: 10.1177/1040638713485073.

I feel that reference to ELISA is needed. I trust the RBT results reported in this study. However, "true" result may be misleading. Indeed, infected animals may be classified negaltive by RBT but positive by iELISA. So, a word of explanation is needed here.

Additional comment about pollution and immunocompromition:

Actually, the link is difficult to demonstrate beyond a general statement.

Nymo I.H., das Neves C.G., Tryland M., Bårdsen B.J., Santos R.L., Turchetti A.P., Janczak A.M., Djønne B., Lie E., Berg V., Godfroid J. 2014. Brucella pinnipedialis hooded seal (Cystophora cristata) strain in the mouse model with concurrent exposure to PCB 153. Comp. Immunol. Microbiol. Infect. Dis., 37: 195-204. doi: 10.1016/j.cimid.2014.01.005.

So, a word of caution could be needed.

Reviewer #2: This version of the manuscript is a good improvement from the previous version. There are some issues that I think are important to address, related mainly with the description of methods used. This can help to reproduce data by independent researchers.

Materials and Methods section

Move:

252All strains isolated from the striped dolphins under study were identified asassigned to B. ceti using

253 the PCR-RFLP method [51149] and then subjected to genomic analysis at the OIE and National and

254 OIE Reference Laboratory for Brucellosis, Istituto Zooprofilattico Sperimentale dell’of Abruzzo e

255 del and Molise, Teramo, Italy.

To the WGS section and rephrase accordingly, assuming that the same DNA extraction method was used.

261 The reactions were loaded as previously reported using B. suis bv 2 strain Thomsen and no template

262 control as positive and negative controls, respectively

No clear to this reviewer what this means. Please specify what was added in a no template control as positive and what is a negative control under this context. A proper negative control should include a sample from a similar animal or tissue from the same animal where no isolation of Brucella was obtained. No evidence of standardization of this PCR for cetacean tissues is given, therefore, this control is essential

As stated by the authors in their response, please include the following info the related to selection criteria of the public genomes used in the study:

“We did however limit our dataset to non-identical sequences and the sequences that mapped to the reference with less than 500 ambiguous matches.”

According to the answer given by the authors:

"As described in Materials and Methods section, two strains of B. ceti isolated in Italy (10759 and 28753) were sequenced by our laboratory previously using Ion Torrent technology."

And a quick database search, it seems that these sequences were already published. If that is the case, please refer properly.

Results section

First lane: “Post-mortem and histopathological investigations were performed on seven positive animals”

I assume it means seven of the eight animals with positive culture for Brucella?

Supplementary Table 2

Please add references for all methods used, particularly those used for parasites

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Jacques Godfroid

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Oct 2;15(10):e0240178. doi: 10.1371/journal.pone.0240178.r004

Author response to Decision Letter 1


18 Sep 2020

Reviewer #1:

Reviewer #1: I have 1 comment that perhaps need an explanatory sentence and reference in the final manuscript.

Serology:

The RBT has limitations when used in wildlife species, particularly marine mammals. therefore ELISAs are excellent alternatives. More, a "universal" indirect ELISA for detecting antibodies in mammals, including marine mammals has been described and documented: Nymo I.H., Godfroid J., Asbakk K., Larsen A.K., das Neves C.G., Rødven R., Tryland M. 2013. A protein A/G indirect enzyme-linked immunosorbent assay for the detection of anti-Brucella antibodies in Arctic wildlife. J. Vet. Diagn. Invest., 25: 369-375. doi: 10.1177/1040638713485073.

I feel that reference to ELISA is needed. I trust the RBT results reported in this study. However, "true" result may be misleading. Indeed, infected animals may be classified negaltive by RBT but positive by iELISA. So, a word of explanation is needed here.

We thank the reviewer for the suggestion, we modified the text accordingly. Now it reads:

”The limited number of samples hampers any conclusion on the use of RBT for the detection of Brucella infection in dolphins. Nevertheless, the fact that the positive result was obtained by testing a fresh serum sample collected from an animal in a good conservation code, supports a true positive result [11]. Moreover, the negative serological findings are supported by the simultaneous detection of other antibodies in case 5 and a supposed immunocompromised host response in case 6, in presence of a widespread DMV infection. RBT test, while generally considered consistent, may produce false results due to variety of factors [65]. Therefore, in order to screen the immunological status of the examined animals, other serological tests such as ELISA could be used, as previously shown [66]. Although some discrepancies between results of RBT and ELISA tests have been reported, ELISA tests, such as iELISA have been successfully used to detect anti-Brucella antibodies in odontocetes and arctic wildlife [65, 66] and could therefore serve as a complementary method serological response to B. ceti in dolphins.”

Additional comment about pollution and immunocompromition:

Actually, the link is difficult to demonstrate beyond a general statement.

Nymo I.H., das Neves C.G., Tryland M., Bårdsen B.J., Santos R.L., Turchetti A.P., Janczak A.M., Djønne B., Lie E., Berg V., Godfroid J. 2014. Brucella pinnipedialis hooded seal (Cystophora cristata) strain in the mouse model with concurrent exposure to PCB 153. Comp. Immunol. Microbiol. Infect. Dis., 37: 195-204. doi: 10.1016/j.cimid.2014.01.005.

So, a word of caution could be needed.

We thank the reviewer for the observation. We wrote again the sentence to make the statement more appropriate. Now it reads:

Moreover, a detailed understanding of the effects of pollutant-related immunotoxicity on pathogenicity of B. ceti, as suggested by some case reports (16, 69), is required, particularly in light of conflicting result obtained using ex vivo model (70).

Line 470.

Reviewer #2:

Reviewer #2: This version of the manuscript is a good improvement from the previous version. There are some issues that I think are important to address, related mainly with the description of methods used. This can help to reproduce data by independent researchers.

Materials and Methods section

Move:

252All strains isolated from the striped dolphins under study were identified asassigned to B. ceti using

253 the PCR-RFLP method [51149] and then subjected to genomic analysis at the OIE and National and

254 OIE Reference Laboratory for Brucellosis, Istituto Zooprofilattico Sperimentale dell’of Abruzzo e

255 del and Molise, Teramo, Italy.

To the WGS section and rephrase accordingly, assuming that the same DNA extraction method was used.

Revised accordingly. The DNA extraction was moved at the line 204.

261 The reactions were loaded as previously reported using B. suis bv 2 strain Thomsen and no template

262 control as positive and negative controls, respectively

No clear to this reviewer what this means. Please specify what was added in a no template control as positive and what is a negative control under this context. A proper negative control should include a sample from a similar animal or tissue from the same animal where no isolation of Brucella was obtained. No evidence of standardization of this PCR for cetacean tissues is given, therefore, this control is essential.

We regret that the sentence was unclear but in the statement we reported the use of B. suis bv 2 strain Thomsen as positive control and no template control for the negative control. Typically, a negative control for PCR is one sample that should not give amplicons, therefore, any visible bands might be a result of contamination or non-specific amplification. The lab works under ISO/IEC 17025 regulation and has validation procedure for the diagnostic tests therefore the PCR was analytically validated for detecting Brucella DNA.

Moreover using tissue samples from bacteriological negative animals could be misleading because there is the possibility of finding dead cells or free DNA from Brucella that gives you positive PCR reactions and negative bacteriological isolation. This situation could be even more evident using tissue from the same animal where you may find positive bacteriological results from one tissue and negative bacteriological from another one.

We revised for clarity the line 219. Now it reads: “The reactions were loaded as previously reported using B. suis bv 2 strain Thomsen as positive control and no template control as negative control.”

As stated by the authors in their response, please include the following info the related to selection criteria of the public genomes used in the study:

“We did however limit our dataset to non-identical sequences and the sequences that mapped to the reference with less than 500 ambiguous matches.”

As suggested, we inserted the following sentence in Materials and methods section:

“The dataset was limited to non-identical sequences that mapped to the B. ceti reference genome with less than 500 ambiguous matches (GenBank Accession Numbers NC_022905.1; NC_022906.1)”

Line 259.

According to the answer given by the authors:

"As described in Materials and Methods section, two strains of B. ceti isolated in Italy (10759 and 28753) were sequenced by our laboratory previously using Ion Torrent technology."

And a quick database search, it seems that these sequences were already published. If that is the case, please refer properly.

Revised accordingly, citing the reference 42:

Ancora M, Marcacci M, Orsini M, Zilli K, Di Giannatale E, Garofolo G, et al. Complete Genome Sequence of a Brucella ceti ST26 Strain Isolated from a Striped Dolphin (Stenella coeruleoalba) on the Coast of Italy. Genome Announc. 2014 Mar 6;2(2). pii: e00068-14. doi: 10.1128/genomeA.00068-14.

Line 257.

Results section

First lane: “Post-mortem and histopathological investigations were performed on seven positive animals”

I assume it means seven of the eight animals with positive culture for Brucella?

Yes. We revised for clarity the line, specifying appropriately.

Line 278.

Supplementary Table 2

Please add references for all methods used, particularly those used for parasites

We thank the reviewer for the suggestion. We modified the Supplementary Table 2 accordingly, and we added the references for methods used for parasites in the Section “Necropsy and diagnostic investigations”:

Line 161.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Roy Martin Roop II

22 Sep 2020

Occurrence of Brucella ceti in striped dolphins from Italian Seas

PONE-D-20-10982R2

Dear Dr. Grattarola,

Thank you for your quick turnaround on the manuscript! I'm pleased to inform you that it has now been judged scientifically suitable for publication and will be formally accepted once it meets any necessary technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Sincerely,

R. Martin Roop II, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Roy Martin Roop II

25 Sep 2020

PONE-D-20-10982R2

Occurrence of Brucella ceti in striped dolphins from Italian Seas

Dear Dr. Grattarola:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Roy Martin Roop II

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Full description of gross and microscopical findings, associated with complete diagnostic test results and the most likely cause of death for each case considered.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The WGS data is submitted at NCBI GenBank with the following accession number: PRJNA623338.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES